Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-25-006066
Filing Date
2025-06-09
Accepted
2025-06-09 16:36:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 28847
2 filename2.txt TEXT-EXTRACT 2051
  Complete submission text file 0000000000-25-006066.txt   42587
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filed for) CIK: 0001693011 (see all company filings)

EIN.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 005-91586
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)